Evolving Biotechnologies with Olga Troya...

Recently, a16z Bio + Health general partner Julie Yoo spoke with Nikita Singareddy, cofounder of Fortuna, and Florian Otto, cofounder of Cedar. They talked about why healthcare affordability is reaching a breaking point, how AI voice agents are transforming patient financial expe ... Show More

Out-of-Pocket is a healthcare education company founded by Nikhil Krishnan that helps people understand how healthcare works and how to navigate it in practice. In this episode, a16z investing partner Jay Rughani and Nikhil discuss why health insurance is losing its role as the d ... Show More

Cofounders Jeremy Wohlwend and Gabriele Corso join the a16z podcast to discuss the launch of Boltz, a public benefit company building AI infrastructure for molecular biology. The conversation explains how breakthroughs following AlphaFold moved the field beyond protein structure ... Show More

<p>In this episode, vanguard geneticist <a href='https://wyss.harvard.edu/team/core-faculty/george-church/'>Dr. George Church</a> recounts his storied career from his early fascination with computers and science to his pioneering work in genomics and synthetic biology. Dr. Church ... Show More

<p>Kevin Hrusovsky, CEO of Quanterix and the Powering Precision Health Summit founder, joins me on the Tech Talks Daily Podcast. Kevin has more than 25 years of experience leading life sciences and biotechnology companies and believes that accelerating precision medicine is the k ... Show More

"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More

"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More

"We've been promised a future of chrome -- but what if the future is fleshy?" asks biological designer Christina Agapakis. In this awe-inspiring talk, Agapakis details her work in synthetic biology -- a multidisciplinary area of research that pokes holes in the line between what' ... Show More

In the decade since the genome editing capabilities of CRISPR-Cas9 emerged, research into novel medicines has boomed – but alongside progress comes new ethical considerations. Controversy erupted in 2018, when Chinese scientist He Jiankui created the first babies with edited geno ... Show More

Cours du 14 février 2007 - 2ème heureCollège de FranceLa biotechnologie va permettre dans l'avenir d'améliorer considérablement le traitement des malades. Elle va permettre d'augmenter l'espérance de vie. Mais cette industrie devra résoudre certains problèmes éthiques comme le cl ... Show More

<p>In this episode of the AI Grand Rounds podcast, <a href='https://www.insitro.com/leadership/daphne-koller/'>Dr. Daphne Koller</a> charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued ... Show More